These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6266576

  • 1. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
    MacGregor GA, Markandu ND, Bayliss J, Roulston JE, Squires M, Morton JJ.
    Br Med J (Clin Res Ed); 1981 Aug 08; 283(6288):401-3. PubMed ID: 6266576
    [Abstract] [Full Text] [Related]

  • 2. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 3. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
    Azizi M, Guyene TT, Chatellier G, Wargon M, Ménard J.
    Hypertension; 1997 Feb 15; 29(2):634-40. PubMed ID: 9040450
    [Abstract] [Full Text] [Related]

  • 4. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug 15; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 5. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
    Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL.
    Br J Clin Pharmacol; 1981 May 15; 11(5):461-7. PubMed ID: 6268131
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H.
    J Cardiovasc Pharmacol; 1982 May 15; 4(6):966-72. PubMed ID: 6185790
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
    Gavras H, Biollaz J, Waeber B, Brunner HR, Gavras I, Davies RO.
    Lancet; 1981 Sep 12; 2(8246):543-7. PubMed ID: 6116000
    [Abstract] [Full Text] [Related]

  • 8. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore TJ, Dluhy RG.
    J Clin Endocrinol Metab; 1983 Oct 12; 57(4):764-70. PubMed ID: 6309884
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
    Wilkes BM.
    J Cardiovasc Pharmacol; 1984 Oct 12; 6(6):1036-42. PubMed ID: 6084759
    [Abstract] [Full Text] [Related]

  • 10. Acute effects of MK421, a new angiotensin converting enzyme inhibitor, in man.
    Kasai Y, Abe K, Yasujima M, Tajima J, Seino M, Chiba S, Sato K, Goto T, Omata K, Tanno M.
    Tohoku J Exp Med; 1983 Dec 12; 141(4):417-22. PubMed ID: 6322384
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Ajayi AA, Hockings N, Reid JL.
    Br J Clin Pharmacol; 1986 Apr 12; 21(4):349-57. PubMed ID: 3011047
    [Abstract] [Full Text] [Related]

  • 16. Duration of action and short-term hormonal responses to enalapril (MK 421) in normal subjects.
    Given BD, Taylor T, Hollenberg NK, Williams GH.
    J Cardiovasc Pharmacol; 1984 Apr 12; 6(3):436-41. PubMed ID: 6202969
    [Abstract] [Full Text] [Related]

  • 17. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE, Gillespie JB.
    Fed Proc; 1984 Apr 12; 43(5):1336-41. PubMed ID: 6323226
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.